4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001104659-21-032853
Options or other derivatives
- Chief Financial Officer acquired 430,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Elefant Dov Chief Financial Officer | 2021-03-04 | Grant or award · Stock option (right to buy) | +430,000 | 430,000 | D | ||
Loading xslF345X03/tm218888d4_4.xml…